[1] Tranquilli A L, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy:a revised statement from the ISSHP[J]. Preg Hypertens, 2014, 4(2):97-104. [2] Cunningham M W, Castillo J, Ibrahim T, et al. AT1-AA (angiotensin Ⅱ type 1 receptor agonistic autoantibody) blockade prevents preeclamptic symptoms in placental ischemic rats[J]. Hypertension, 2018, 71(5):886-893. [3] Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor[J]. J Clin Invest, 1999, 103(7):945-952. [4] Lei J, Li Y, Zhang S, et al. The prognostic role of angiotensin Ⅱ type 1 receptor autoantibody in non-gravid hypertension and pre-eclampsia:a meta-analysis and our studies[J]. Medicine (Baltimore), 2016, 95(17):e3494. [5] Zhou C C, Zhang Y, Irani R A, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice[J]. Nat Med, 2008, 14(8):855-862. [6] Yang J, Li L, Shang J Y, et al. Angiotensin Ⅱ type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia[J]. J Hypertension, 2015, 33(5):1046-1056. [7] LaMarca B, Wallace K, Granger J. Role of angiotensin Ⅱ type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia[J]. Curr Opin Pharmacol, 2011, 11(2):175-179. [8] Cunningham M W, Williams J M, Amaral L, et al. Agonistic autoantibodies to the angiotensin Ⅱ type 1 receptor enhance angiotensin Ⅱ-induced renal vascular sensitivity and reduce renal function during pregnancy[J]. Hypertension, 2016, 68(5):1308-1313. [9] Zhang S, Zheng R, Yang L, et al. Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction[J]. J Cell Physiol, 2013, 228(1):142-148. [10] Yang X, Wang F, Chang H, et al. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation[J]. J Hypertens, 2008, 26(8):1629-1635. [11] Wang B, Liao Y, Zhou Z, et al. Arterial structural changes in rats immunized by AT1-receptor peptide[J]. Heart Vessels, 2005, 20(4):153-158. [12] Parrish M R, Murphy S R, Rutland S, et al. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin Ⅱ type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy[J]. Am J Hypertens, 2010, 23(8):911-916. [13] Harmon A C, Cornelius D C, Amaral L M, et al. The role of inflammation in the pathology of preeclampsia[J]. Clin Sci (Lond), 2016, 130(6):409-419. [14] 张真真, 戴姝艳.血管紧张素Ⅱ2型受体对大鼠子宫内膜异位症血管生成的影响[J].中国医科大学学报,2018,47(9):792-796. |